micro-community-banner
 
  • Saved

April 21, 2025
A Case of Pediatric Myasthenia Revealed by Marked Eyelid Ptosis After Using Cyclopentolate Eye Drops - PubMed

A Case of Pediatric Myasthenia Revealed by Marked Eyelid Ptosis After Using Cyclopentolate Eye Drops - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/40177434/

Pediatric myasthenia gravis (PMG), while uncommon, poses significant diagnostic challenges due to its potential impact on development and its often subtle initial symptoms, such as ptosis and diplopia. This case...

https://pubmed.ncbi.nlm.nih.gov/40177434/

A three-year-old girl’s persistent ptosis, initially mistaken for a chalazion, led to a pediatric myasthenia gravis diagnosis, emphasizing early recognition, caregiver observations, and comprehensive pediatric ophthalmologic evaluations.

Profile Image
  • Saved

April 21, 2025
The clinical significance of open vs. minimally invasive surgical approaches in the management of thymic epithelial tumors and myasthenia gravis - PubMed

The clinical significance of open vs. minimally invasive surgical approaches in the management of thymic epithelial tumors and myasthenia gravis - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/39723340/

Though advancements have been made in the pharmacologic treatment of myasthenia gravis (MG), surgical resection is not only an option as a last line of defense for those patients who...

https://pubmed.ncbi.nlm.nih.gov/39723340/

Though minimally invasive techniques like RATS/VATS show promise for thymectomy with fewer complications, debate persists over their oncologic adequacy versus open surgery, especially for achieving complete resection (R0) in malignancies.

Profile Image
  • Saved

April 17, 2025
American Academy of Neurology Annual Meeting

The 2025 American Academy of Neurology (AAN) Annual Meeting spanned five days and featured more than 3,200 abstracts. Held at the San Diego Convention Center and online, the meeting’s program covered the full spectrum of neurological conditions, including multiple sclerosis (MS), headache, chronic inflammatory demyelinating polyneuropathy, myasthenia gravis, and more. More than 14,000 experts convened at the meeting to share timely and state-of-the-art research and advances.

Above, please find our postconference wrap-up report.

  • Saved

April 14, 2025
Advances in sulodexide-based long-term anticoagulation for a myasthenia gravis patient with giant thymoma - PubMed

Advances in sulodexide-based long-term anticoagulation for a myasthenia gravis patient with giant thymoma - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/40078295/

This case report describes a geriatric male patient with myasthenia gravis (MG) secondary to giant thymoma, presenting with progressive muscle weakness and ptosis. The diagnosis of MG was confirmed through...

A geriatric myasthenia gravis patient with giant thymoma developed thrombosis and HIT during treatment; sulodexide proved a safe, effective long-term anticoagulant with no adverse events over 3 years.

Profile Image
  • Saved

April 14, 2025
Tracking myasthenia gravis severity over time: Insights from the French health insurance claims database - PubMed

Tracking myasthenia gravis severity over time: Insights from the French health insurance claims database - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/39494501/

A subgroup of patients with MG require ICU admission and rescue therapy with IVIg or PE, indicative of poor disease control. New therapies are needed to improve disease control and...

This study assessed MG severity using French health data, showing early ICU use and treatment needs, with mortality linked to age, gender, and comorbidity, underscoring the need for better therapies.

Profile Image